United Therapeutics (NASDAQ: UTHR) pushes inhaled therapy strategy as Phase 3 Tyvaso data shows lung function preservation in IPF
Read More 4 minute read Healthcare Industry News Inocras launches MRDVision with ppm-level sensitivity, setting new standard in cancer recurrence detection Inocras launches MRDVision with ppm-level ctDNA sensitivity, setting a new MRD testing standard—discover how it could transform cancer monitoring today. byPallavi MadhirajuApril 28, 2025